Applying a bitter substance to the nails for people who tend to bite their nails is a form of which type of therapy?
Role modeling
Aversion therapy
Milieu therapy
Desensitization therapy
The Correct Answer is B
Choice A reason: Role modeling involves demonstrating positive behaviors for others to emulate, often used in social learning. It does not involve applying negative stimuli like bitter substances to deter behaviors. Nail-biting treatment requires a direct intervention to discourage the habit, making this choice scientifically inappropriate.
Choice B reason: Aversion therapy uses an unpleasant stimulus, like a bitter substance, to create a negative association with an undesired behavior, such as nail-biting. This behavioral technique aims to reduce the behavior through conditioning, aligning with the described intervention, making this the correct choice for the therapy type.
Choice C reason: Milieu therapy focuses on creating a therapeutic environment to promote mental health, not targeting specific behaviors like nail-biting. It involves group dynamics and structured settings, not aversive stimuli. This approach is unrelated to the described intervention, making this choice incorrect.
Choice D reason: Desensitization therapy gradually exposes individuals to anxiety-provoking stimuli to reduce fear, commonly used for phobias. It does not involve aversive stimuli to deter behaviors like nail-biting. This therapy is unrelated to the described intervention, making it an incorrect choice for this scenario.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Choice A reason: Trust versus mistrust, Erikson's first psychosocial stage (0–1 year), focuses on developing trust in caregivers for basic needs. Failure leads to fear and suspicion, not feelings of worthlessness or insignificance. These symptoms do not align with the adult’s statements about opinions not counting, making this choice scientifically inaccurate for the described crisis.
Choice B reason: Autonomy versus shame and doubt, Erikson’s second stage (1–3 years), involves gaining independence in actions like self-care. Failure results in shame and self-doubt about autonomy, not a broader sense of worthlessness or lack of influence. This stage is unrelated to the adult’s expressed feelings, rendering this choice incorrect.
Choice C reason: Initiative versus guilt, the third stage (3–6 years), centers on initiating activities and asserting control. Failure leads to guilt over actions, not a diminished sense of self-worth or influence. The adult’s statements reflect identity struggles, not guilt from initiative, so this choice does not fit the psychosocial crisis described.
Choice D reason: Identity versus role confusion, Erikson’s fifth stage (12–18 years), involves forming a cohesive self-identity. Failure leads to role confusion, low self-esteem, and feelings of insignificance, directly aligning with the adult’s statements about having no answers and opinions not counting. This unresolved crisis persists into adulthood, making this the correct choice.
Correct Answer is ["B","C"]
Explanation
Choice A reason: Bupropion is not primarily a sedative; it is an atypical antidepressant that stimulates norepinephrine and dopamine. It may cause insomnia, not promote sleep, making this statement incorrect. Sedative medications like zolpidem are used for sleep, not bupropion, which has activating properties.
Choice B reason: Bupropion has a lower risk of sexual dysfunction compared to SSRIs, making it a suitable alternative for depression treatment in patients experiencing this side effect. Its mechanism avoids serotonin-related sexual issues, supporting its use in such cases, making this a correct choice.
Choice C reason: Bupropion is FDA-approved for major depressive disorder, acting on norepinephrine and dopamine to alleviate depressive symptoms. It is commonly prescribed for depression, making this statement true and a correct choice, as it aligns with its primary clinical use.
Choice D reason: Bupropion, under the brand Zyban, is approved for smoking cessation, as it reduces nicotine cravings and withdrawal symptoms by modulating dopamine pathways. This evidence-based use makes the statement true, correctly identifying bupropion’s role in smoking cessation programs.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.